The Armed Forces Institute of Regenerative Medicine (AFIRM II) is offering this grant to advance regenerative medicine technologies and associated sciences. This grant aims to develop therapies for traumatically injured Wounded Warriors, with benefits extending to the civilian sector. The program focuses on funding basic through translational regenerative medicine research and development, including animal models, preclinical studies, and initial human clinical trials (Phases I-II). A key objective is to transition promising technologies into human clinical trials and ultimately achieve FDA-approved treatments. Offerors are encouraged to establish partnerships with industry to facilitate clinical applications and seek collaborations with government laboratories and medical centers for mutually beneficial outcomes.
Opportunity ID: 164713
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-AFIRM-IIRP |
| Funding Opportunity Title: | Armed Forces Institute of Regenerative Medicine – II (AFIRM II) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 16, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 11, 2012 |
| Current Closing Date for Applications: | Jul 11, 2012 |
| Archive Date: | Aug 10, 2012 |
| Estimated Total Program Funding: | $75,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The Armed Forces Institute of Regenerative Medicine (AFIRM) is dedicated to repairing battlefield injuries through the use of regenerative medicine technologies and associated sciences. Therapies developed by the AFIRM II program are intended to aid traumatically injured Wounded Warriors as well as to benefit those within the civilian sector. One of the goals of the program is to position promising technologies and therapeutic/restorative practices for entrance into human clinical trials. The intent of the AFIRM II program is to fund basic through translational regenerative medicine research and development. Activities acceptable under this award may include basic scientific research, development of animal models, preclinical studies required for initiation of FDA-regulated human clinical trials, and Phase I II human clinical trials. Therefore, it is not the intent to fund human clinical trials as a major component of this program. It is envisioned that integration of basic science, translational and clinical research efforts will be necessary to advance effective regenerative medicine treatments for combat-related injuries. The Offerors organization should actively seek out and establish partnerships with industry to ensure that the technical innovations emerging from the research will transition into clinical applications and result in FDA approved treatments. Offerors are encouraged to seek collaboration with Government laboratories and Medical Centers/Medical Treatment Facilities such as those in the Army, Navy, Air Force, NIH and VA, if mutually beneficial. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-682-5507: help@cdmrp.org
eReceipt HELP: 301-682-5507: help@cdmrp.org Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 164713 Full Announcement-1 -> fy13 afirm ii program announcement.pdf
Packages
| Agency Contact Information: | PA HELP: 301-682-5507: help@cdmrp.org eReceipt HELP: 301-682-5507: help@cdmrp.org Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00116510 | Apr 16, 2012 | Jul 11, 2012 | View |
Package 1
Mandatory forms
164713 RR_SF424_1_2-1.2.pdf
164713 PerformanceSite_1_4-1.4.pdf
164713 RR_Budget-1.1.pdf
164713 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
164713 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
